These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8473656)

  • 1. Selective pulmonary and systemic vasodilator effects of amrinone in children: new therapeutic implications.
    Robinson BW; Gelband H; Mas MS
    J Am Coll Cardiol; 1993 May; 21(6):1461-5. PubMed ID: 8473656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute hemodynamic effects of converting enzyme inhibition in children with intracardiac shunts.
    Webster MW; Neutze JM; Calder AL
    Pediatr Cardiol; 1992 Jul; 13(3):129-35. PubMed ID: 1318542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of amrinone on the right side of the heart.
    Hess W
    J Cardiothorac Anesth; 1989 Dec; 3(6 Suppl 2):38-44. PubMed ID: 2521050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute haemodynamic effects of nifedipine in patients with ventricular septal defect.
    Berisha S; Goda A; Kastrati A; Frasheri A; Popa Y
    Br Heart J; 1988 Aug; 60(2):149-55. PubMed ID: 3415874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic correlation with lung biopsy findings in isolated ventricular septal defect with or without pulmonary hypertension.
    Zakaria M
    Hokkaido Igaku Zasshi; 1997 Nov; 72(6):607-19. PubMed ID: 9465314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amrinone and the pulmonary vascular pressure-flow relationship in conscious control dogs and following left lung autotransplantation.
    Nyhan DP; Pribble CG; Peterson WP; Nishiwaki K; Trempy GA; Desai PM; Rock P; Murray PA
    Anesthesiology; 1993 Jun; 78(6):1166-74. PubMed ID: 8512111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic reduction of pretransplantation pulmonary vascular resistance predicts outcome after pediatric heart transplantation.
    Zales VR; Pahl E; Backer CL; Crawford S; Mavroudis C; Benson DW
    J Heart Lung Transplant; 1993; 12(6 Pt 1):965-72; discussion 972-3. PubMed ID: 8312321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemodynamic effects of amrinone, phosphodiesterase inhibitor, early after coronary artery bypass grafting].
    Shibata T; Suehiro S; Minamimura H; Sasaki Y; Ishikawa T; Hattori K; Kinoshita H
    Nihon Kyobu Geka Gakkai Zasshi; 1996 Nov; 44(11):2027-31. PubMed ID: 8958718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of amrinone in children after cardiac surgery.
    Berner M; Jaccard C; Oberhansli I; Rouge JC; Friedli B
    Intensive Care Med; 1990; 16(2):85-8. PubMed ID: 2332544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effects of hydralazine in infants with a large ventricular septal defect.
    Beekman RH; Rocchini AP; Rosenthal A
    Circulation; 1982 Mar; 65(3):523-8. PubMed ID: 6459891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of amrinone and colloid administration in children following cardiac surgery.
    Lynn AM; Sorensen GK; Williams GD; Anderson GD; Opheim KE
    J Cardiothorac Vasc Anesth; 1993 Oct; 7(5):560-5. PubMed ID: 8268437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which anesthetic agent alters the hemodynamic status during pediatric catheterization? Comparison of propofol versus ketamine.
    Oklü E; Bulutcu FS; Yalçin Y; Ozbek U; Cakali E; Bayindir O
    J Cardiothorac Vasc Anesth; 2003 Dec; 17(6):686-90. PubMed ID: 14689405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of patients operated for large ventricular septal defects with increased pulmonary vascular resistance.
    Kannan BR; Sivasankaran S; Tharakan JA; Titus T; Ajith Kumar VK; Francis B; Krishnamoorthy KM; Harikrishnan S; Padmakumar R; Nair K
    Indian Heart J; 2003; 55(2):161-6. PubMed ID: 12921332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary vascular resistance during exercise late after repair of large ventricular septal defects. Relation to age at the time of repair.
    Ikawa S; Shimazaki Y; Nakano S; Kobayashi J; Matsuda H; Kawashima Y
    J Thorac Cardiovasc Surg; 1995 Jun; 109(6):1218-24. PubMed ID: 7776686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of nitroglycerin inhalation in reducing pulmonary arterial hypertension in children with congenital heart disease.
    Goyal P; Kiran U; Chauhan S; Juneja R; Choudhary M
    Br J Anaesth; 2006 Aug; 97(2):208-14. PubMed ID: 16707530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The haemodynamic effects of amrinone in patients with mitral stenosis and pulmonary hypertension.
    Hess W; Arnold B; Veit S
    Eur Heart J; 1986 Sep; 7(9):800-7. PubMed ID: 3769960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative actions of hydralazine, nifedipine and amrinone in primary pulmonary hypertension.
    Rich S; Ganz R; Levy PS
    Am J Cardiol; 1983 Nov; 52(8):1104-7. PubMed ID: 6637831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of nitroprusside in infants with a large ventricular septal defect.
    Beekman RH; Rocchini AP; Rosenthal A
    Circulation; 1981 Sep; 64(3):553-8. PubMed ID: 7261287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects of amrinone in children after Fontan surgery.
    Sorensen GK; Ramamoorthy C; Lynn AM; French J; Stevenson JG
    Anesth Analg; 1996 Feb; 82(2):241-6. PubMed ID: 8561320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Functional studies in rest and during exertion in children and adolescents with ventricular septal defects and pulmonary hypertension].
    Mocellin R; Friedman J; Sebening W; Bühlmeyer K
    Z Kardiol; 1975 Nov; 64(11):1036-52. PubMed ID: 1210513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.